Found 5 matching trials
APRiCOT-B: Study to Evaluate Apricoxib in Combination With Lapatinib and Capecitabine in the Treatment of HER2/Neu+ Breast Cancer (TP2001-202) PHASE2 This study will compare the anti-tumor efficacy of apricoxib and lapatinib/...
Show More Location
Arizona Clinical Research Center
Learn More & Join Trial
APRiCOT-L: Study to Evaluate Efficacy and Safety of Apricoxib With Erlotinib in Patients With Non-small Cell Lung Cancer PHASE2 This study will compare the anti-tumor efficacy of apricoxib and erlotinib ...
Show More Location
Multiple Locations
Learn More & Join Trial
APRiCOT-P: Study of Apricoxib With Gemcitabine and Erlotinib to Treat Advanced Pancreatic Cancer PHASE2 This study will compare the anti-tumor efficacy of apricoxib and gemcitabin...
Show More Location
Arizona Clinical Research Center
Learn More & Join Trial
Evaluation of Apricoxib (Selective Cyclooxygenase 2 Inhibition) in Modulating T Regulatory Cells of Patients With Early Stage Non-small Cell Lung Cancer NA The primary objective for this trial is to determine the biological ability...
Show More Location
Jonsson Comprehensive Cancer Center
Learn More & Join Trial
0822GCC: Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer PHASE2 The primary objective is to determine the anti-tumor activity of the combin...
Show More Location
USC/Norris Comprehensive Cancer Center
Learn More & Join Trial